Oxford BioMedica PLC (LSE:OXB) - Share price - Overview

Stock Report

Oxford BioMedica PLC OXB

Last Price
GBX882.10

Day Change
55.10|6.66%

As of 17/07/2018
18:38:12 BST | GBX
Minimum 15 Minutes Delay.

Last Close827.00p
Day Range780.00 - 882.10
Mkt Cap545.90Mil
52-Wk Range366.00 - 1,062.60
Yield %-
ISINGB00BDFBVT43
Volume381,180
P/E-50.86
P/S0.15
P/CF1.83

Share Price

Total Returns 16/07/2018

 Chg (%)  
More ...
Oxford BioMedica PLC-15.67 
FTSE 100 TR GBP0.03
 
Financials
201520162017
More ...
Income Statement
Turnover15.9127.7837.59
Operating Profit-14.08-11.31-7.97
Net Profit-13.02-16.64-9.02
Reported EPS-25.50-30.00-14.50
Balance Sheet
Current Assets25.7127.4436.98
Non Current Assets26.1429.5028.42
Total Assets51.8556.9465.40
Current Liabilities13.179.3221.76
Total Liabilities40.9644.3359.26
Total Equity10.8912.626.15
Cash Flow
Operating Cash Flow-16.36-5.93-1.53
Net Change in Cash-4.845.98-1.01
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
22/06/2018PurchaseDr. Lorenzo Tallarigo,M.D.1,019.002622,670.00
23/05/2018PurchaseDr. Lorenzo Tallarigo,M.D.15.0017,7022,655.00
23/04/2018PurchaseDr. Lorenzo Tallarigo,M.D.12.0022,0552,647.00
10/04/2018PurchaseMr. Martin Diggle11.001,000,000110,000.00

Company Profile

Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Sector

Biotechnology

Index

FTSE SmallCap ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Next Event 17/08/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-5.38
Op Mrgn-0.21
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, Deputy ChairmanDr. Andrew John William Heath
Non-Executive DirectorMr. Martin Diggle
Executive Director, Chief Business OfficerMr Peter J Nolan
Executive Director, Chief Executive OfficerMr John Dawson
Non-Executive DirectorMr. Stuart Henderson
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.